Free Trial
OTCMKTS:ASNB

EKIMAS (ASNB) Stock Price, News & Analysis

$2.09 +0.19 (+10.00%)
As of 07/16/2025

About EKIMAS Stock (OTCMKTS:ASNB)

Key Stats

Today's Range
$2.00
$2.09
50-Day Range
$1.90
$5.00
52-Week Range
$0.55
$1.75
Volume
440 shs
Average Volume
3,162 shs
Market Capitalization
$12.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ASNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter.

ASNB Stock News Headlines

EKIMAS CORPORATION COMPLETES THE EXERCISE OF WARRANTS
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Updated EKIMAS Corporation Announces Special Cash Distribution
What does ‘WYLL’ mean on TikTok and Snapchat?
EKIMAS Corporation (ASNB)
See More Headlines

ASNB Stock Analysis - Frequently Asked Questions

EKIMAS's stock was trading at $9.00 at the start of the year. Since then, ASNB shares have decreased by 76.8% and is now trading at $2.09.

EKIMAS Co. (OTCMKTS:ASNB) posted its earnings results on Thursday, October, 16th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.29 by $0.02.

Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that EKIMAS investors own include Associated Banc (ASB), MediWound (MDWD), PermRock Royalty Trust (PRT), Meta Platforms (META), Adobe (ADBE), Actinium Pharmaceuticals (ATNM) and CytoDyn (CYDY).

Company Calendar

Last Earnings
10/16/2014
Today
7/18/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Business Services
Current Symbol
OTCMKTS:ASNB
Previous Symbol
AMEX:ASB
CIK
1011060
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$290 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-7,902.31%
Return on Assets
-5,274.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.12
Quick Ratio
0.12

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.03 per share
Price / Book
69.67

Miscellaneous

Outstanding Shares
5,799,000
Free Float
5,347,000
Market Cap
$12.12 million
Optionable
Not Optionable
Beta
0.37
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:ASNB) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners